Studying inflammation and social factors in breast cancer
Part of Cancer, Skin clinical trials.
This study looks at how inflammation and social factors (like stress or support) affect breast cancer patients before they start treatment. You may qualify if you are a woman, newly diagnosed, and have not yet had any cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman 18 years or older
- You have been newly diagnosed with breast cancer (invasive or early stage) and have not yet started treatment
- You are able to walk and take care of yourself (ECOG score 0 or 1)
- You have not had another cancer (except certain skin cancers) in the past 6 months
- You can speak English and give your consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at factors related to breast cancer risk and outcomes. If you are coming to MSK for a breast biopsy or are a new breast cancer patient having surgery there, you may be able to join.
This study asks women with breast cancer to take part in an online, before-and-after research project. It may help researchers understand your experiences and improve support for people living with breast cancer, including those with relapse or spread to other parts of the body.
This trial looks at how breast cancer works in the body, using new “mechanics” measurements to better guide treatment. It may be most helpful if you have (or may have) breast cancer and can take part in study visits and procedures.
This study looks at people who are being screened and just diagnosed with breast cancer and haven’t started treatment yet. It may help researchers understand how to better manage care from the start of treatment.
This study looks at how the immune system changes in people with breast cancer, using patient tissue samples. It may help researchers understand immune responses in young women and guide future cancer treatments.
This study looks at how your immune system changes while you receive standard breast cancer treatments. The researchers measure immune-related signals during your treatment to better understand what may be happening in triple-negative or certain hormone-receptor breast cancers.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.